AMYLO Trademark
Trademark Overview
On Thursday, May 30, 2024, a trademark application was filed for AMYLO with the United States Patent and Trademark Office. The USPTO has given the AMYLO trademark a serial number of 79401325. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, August 5, 2025. This trademark is owned by BeauBrain Healthcare. The AMYLO trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Software as a medical device (SaMD), downloadable, for treating Alzheimer's disease; downloadable computer software for data processing in the field of Alzheimer's disease; downloadable computer software for database management in the field of Alzheimer's disease; downloadable software for processing digital images in the field of Alzheimer's disease; downloadable software for processing images, graphics and text in the field of Alzheimer's disease; downloadable computer software for diagnosing diseases, namely, Alzheimer's disease, for medical purposes; downloadable computer software for use in medical decision support systems in the field of Alzheimer's disease; data processing apparatus for use in the field of Alzheimer's disease; downloadable image files of human brains for use in the field of Alzheimer's disease; downloadable electronic documents in the field of image processing for use in treatment of Alzheimer's disease
Providing medical advice in the field of geriatrics relating to Alzheimer's disease; medical analysis for the diagnosis and treatment of persons with Alzheimer's disease; health care services for treating Alzheimer's disease; remote monitoring of medical data for medical diagnosis and treatment of Alzheimer's disease; medical analysis services for the diagnosis of Alzheimer's disease; medical diagnostic services for Alzheimer's disease; mental health screening services relating to Alzheimer's disease; medical testing services relating to the diagnosis and treatment of Alzheimer's disease; performing diagnosis of Alzheimer's disease; medical advisory services relating to the treatment of degenerative diseases, namely, Alzheimer's disease
Medical apparatus for the diagnosis of cerebrovascular diseases; medical apparatus for the diagnosis of neurological diseases; medical apparatus and instruments for predicting, diagnosing, and treating Alzheimer's disease; apparatus for carrying-out diagnostic tests for Alzheimer's disease for medical purposes; diagnostic apparatus for diagnosing Alzheimer's disease for medical purposes; radiological diagnostic imaging apparatus, namely, Positron Emission Tomography (PET), Computed Tomography (CT), and Magnetic Resonance Imager (MRI) for medical purposes relating to diagnosis and treatment of Alzheimer's disease; diagnostic measuring apparatus for medical use for measuring beta-amyloid plaque for use in the diagnosis and tratment of Alzheimer's disease; medical apparatus and instruments, namely, apparatus for medical diagnostic testing for use in the fields of clinical diagnosis of Alzheimer's disease; automatic analyzers in the nature of PET, CT, and MRI for medical diagnosis of Alzhe...
Software as a service (SAAS) services featuring software for image processing for use in diagnosis and treatment of Alzheimer's disease; technological and scientific remote monitoring services relating to the function of medical diagnostic devices in the field of Alzheimer's disease; research and development of medical apparatus and instruments for use in Alzheimer's disease medical diagnostic testing for others; research and development of medical equipment for use in Alzheimer's disease medical diagnostic testing; research and development of medical devices for use in Alzheimer's disease medical diagnostic testing; providing technological support services, namely, providing technical advice related to the research and development of medical diagnostic instruments for use in diagnosing Alzheimer's disease; technological and scientific monitoring services relating to the function of Alzheimer's disease medical diagnostic instruments; technology consultation in the field of artificial i...
General Information
Serial Number | 79401325 |
Word Mark | AMYLO |
Filing Date | Thursday, May 30, 2024 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Tuesday, August 5, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 26, 2025 |
Trademark Statements
Goods and Services | Software as a medical device (SaMD), downloadable, for treating Alzheimer's disease; downloadable computer software for data processing in the field of Alzheimer's disease; downloadable computer software for database management in the field of Alzheimer's disease; downloadable software for processing digital images in the field of Alzheimer's disease; downloadable software for processing images, graphics and text in the field of Alzheimer's disease; downloadable computer software for diagnosing diseases, namely, Alzheimer's disease, for medical purposes; downloadable computer software for use in medical decision support systems in the field of Alzheimer's disease; data processing apparatus for use in the field of Alzheimer's disease; downloadable image files of human brains for use in the field of Alzheimer's disease; downloadable electronic documents in the field of image processing for use in treatment of Alzheimer's disease |
Goods and Services | Providing medical advice in the field of geriatrics relating to Alzheimer's disease; medical analysis for the diagnosis and treatment of persons with Alzheimer's disease; health care services for treating Alzheimer's disease; remote monitoring of medical data for medical diagnosis and treatment of Alzheimer's disease; medical analysis services for the diagnosis of Alzheimer's disease; medical diagnostic services for Alzheimer's disease; mental health screening services relating to Alzheimer's disease; medical testing services relating to the diagnosis and treatment of Alzheimer's disease; performing diagnosis of Alzheimer's disease; medical advisory services relating to the treatment of degenerative diseases, namely, Alzheimer's disease |
Goods and Services | Medical apparatus for the diagnosis of cerebrovascular diseases; medical apparatus for the diagnosis of neurological diseases; medical apparatus and instruments for predicting, diagnosing, and treating Alzheimer's disease; apparatus for carrying-out diagnostic tests for Alzheimer's disease for medical purposes; diagnostic apparatus for diagnosing Alzheimer's disease for medical purposes; radiological diagnostic imaging apparatus, namely, Positron Emission Tomography (PET), Computed Tomography (CT), and Magnetic Resonance Imager (MRI) for medical purposes relating to diagnosis and treatment of Alzheimer's disease; diagnostic measuring apparatus for medical use for measuring beta-amyloid plaque for use in the diagnosis and tratment of Alzheimer's disease; medical apparatus and instruments, namely, apparatus for medical diagnostic testing for use in the fields of clinical diagnosis of Alzheimer's disease; automatic analyzers in the nature of PET, CT, and MRI for medical diagnosis of Alzheimer's disease; electromedical diagnostic instruments for diagnosing Alzheimer's disease |
Translation of Words in Mark | The wording "AMYLO" has no meaning in a foreign language. |
Goods and Services | Software as a service (SAAS) services featuring software for image processing for use in diagnosis and treatment of Alzheimer's disease; technological and scientific remote monitoring services relating to the function of medical diagnostic devices in the field of Alzheimer's disease; research and development of medical apparatus and instruments for use in Alzheimer's disease medical diagnostic testing for others; research and development of medical equipment for use in Alzheimer's disease medical diagnostic testing; research and development of medical devices for use in Alzheimer's disease medical diagnostic testing; providing technological support services, namely, providing technical advice related to the research and development of medical diagnostic instruments for use in diagnosing Alzheimer's disease; technological and scientific monitoring services relating to the function of Alzheimer's disease medical diagnostic instruments; technology consultation in the field of artificial intelligence for use in the field of diagnosing and treating Alzheimer's disease; research and development of diagnostic apparatus for use in diagnosing Alzheimer's disease; computer aided diagnostic testing services for use in diagnosing Alzheimer's disease |
Classification Information
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 1, 2024 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 1, 2024 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 1, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 1, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | BeauBrain Healthcare |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | KR |
Trademark Events
Event Date | Event Description |
Thursday, August 1, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Tuesday, August 6, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, August 6, 2024 | APPLICATION FILING RECEIPT MAILED |
Thursday, December 12, 2024 | ASSIGNED TO EXAMINER |
Thursday, December 12, 2024 | NON-FINAL ACTION WRITTEN |
Friday, December 13, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Friday, December 27, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Friday, December 27, 2024 | REFUSAL PROCESSED BY MPU |
Friday, January 17, 2025 | REFUSAL PROCESSED BY IB |
Friday, June 27, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, June 27, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, June 27, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, July 18, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Friday, July 18, 2025 | EXAMINER'S AMENDMENT ENTERED |
Friday, July 18, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, July 18, 2025 | EXAMINERS AMENDMENT -WRITTEN |
Friday, July 18, 2025 | EXAMINERS AMENDMENT E-MAILED |